Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
37.36
-2.36 (-5.94%)
At close: Mar 31, 2025, 4:00 PM
36.00
-1.36 (-3.64%)
After-hours: Mar 31, 2025, 6:40 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.17 billion as of March 31, 2025. Its market cap has decreased by -43.77% in one year.
Market Cap
2.17B
Enterprise Value
1.45B
1-Year Change
-43.77%
Ranking
Category
Stock Price
$37.36
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.17B, an increase of 168.29%. That is a compound annual growth rate of 78.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.31B | -10.49% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.83B |
| UnitedHealth Group | 481.39B |
| Johnson & Johnson | 399.53B |
| AbbVie | 370.02B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 229.87B |
| AstraZeneca | 225.46B |
| Merck & Co. | 225.10B |